No country has approved injectable afamelanotide for tanning or general photoprotection
Wegovy is approved for chronic weight management in people with obesity or overweight with weight-related health conditions
This may include questions about metabolic health, prior weight loss attempts, lab work, or conditions that could affect eligibility
This absence of data is itself clinically significant it means that any combined use would occur without a formal safety profile for this specific pairing
By combining expert medical oversight with ongoing lifestyle support, Brello provides a science-driven, patient-first approach for sustainable weight management
While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy